These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28932793)

  • 1. Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system.
    van der Knaap RHP; Kwekkeboom DJ; Ramakers CRB; de Rijke YB
    Pract Lab Med; 2015 Apr; 1():5-11. PubMed ID: 28932793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated two-site immunofluorescent assay for the measurement of serum chromogranin A.
    Popovici T; Moreira B; Schlageter MH; Bories PN
    Clin Biochem; 2014 Jan; 47(1-2):87-91. PubMed ID: 24201067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement.
    Choi YJ; Roh J; Kim S; Lee KA; Park Y
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two chromogranin A assays and investigation of nonlinear specimens.
    Erickson JA; Chiang FI; Walker CM; Genzen JR; Doyle K
    Pract Lab Med; 2022 Nov; 32():e00299. PubMed ID: 36035319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CisBio ELISA for Chromogranin A Measurement.
    Lim M; Erdman P; Cho S; Mathew A; Fleisher M; Thoren KL
    J Appl Lab Med; 2019 Jul; 4(1):11-18. PubMed ID: 31639703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the automated KRYPTOR chromogranin A assay with the DAKO ELISA.
    Wolf M; Riedlinger I; Lehmann R; Häring HU; Schleicher E; Peter A
    Clin Lab; 2014; 60(12):2103-6. PubMed ID: 25651748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin A: any relevance in neuroendocrine tumors?
    Kidd M; Bodei L; Modlin IM
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):28-37. PubMed ID: 26627724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three commercially available ELISA kits for the determination of chromogranin A.
    Eeckhout K; Van Cotthem K; Guerti K
    J Immunoassay Immunochem; 2021 Mar; 42(2):95-105. PubMed ID: 33043835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects.
    Mosli HH; Dennis A; Kocha W; Asher LJ; Van Uum SH
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1731-5. PubMed ID: 22723311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours.
    Korse CM; Muller M; Taal BG
    Br J Cancer; 2011 Oct; 105(8):1173-5. PubMed ID: 21989216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A as a Biochemical Marker for Neuroendocrine Tumors: A Single Center Experience at Royal Hospital, Oman.
    Al-Risi ES; Al-Essry FS; Mula-Abed WS
    Oman Med J; 2017 Sep; 32(5):365-370. PubMed ID: 29026467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
    Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
    Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors.
    Baekdal J; Krogh J; Klose M; Holmager P; Langer SW; Oturai P; Kjaer A; Federspiel B; Hilsted L; Rehfeld JF; Knigge U; Andreassen M
    Diagnostics (Basel); 2020 Oct; 10(11):. PubMed ID: 33138020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
    Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
    Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
    Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
    Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors.
    Ferrari L; Seregni E; Lucignani G; Bajetta E; Martinetti A; Aliberti G; Pallotti F; Procopio G; Della Torre S; Luksch R; Bombardieri E
    Int J Biol Markers; 2004; 19(4):295-304. PubMed ID: 15646836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
    Nölting S; Kuttner A; Lauseker M; Vogeser M; Haug A; Herrmann KA; Hoffmann JN; Spitzweg C; Göke B; Auernhammer CJ
    Cancers (Basel); 2012 Feb; 4(1):141-55. PubMed ID: 24213232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
    Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
    Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Italian program of external quality control for chromogranin A (CgA) assay: state of the art of CgA measurement.
    Italian Network for Quality Assessment of Tumor Biomarkers Group
    Int J Biol Markers; 2005; 20(4):264-8. PubMed ID: 16398409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
    Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.